Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

Hutchmed - Li Ka-shing's cancer drug company

In March, Hutchmed's CEO of the last 15 years, Christian Hogg resigned...

May 10, 2022

V.TLT

RE:RE:RE:Good news regarding the FDA

Great posts ScienceDirect! Our day is coming fast! ScienceFirst wrote: It'...

May 10, 2022

V.TLT

RE:RE:RE:RE:RE:How close are we to needing CASH?

Hi jmm1228.  Most definitely a typo. You missed one letter and...

May 8, 2022

V.TLT

RE:Is BCG unresponsive NMIBC unique?

A pivotal trial is one that attempts to demonstrate the efficacy of a drug in...

May 8, 2022

V.TLT

Is BCG unresponsive NMIBC unique?

One of the main reasons Theralase chose BCG unresponsive NMIBC as their first...

May 7, 2022

V.TLT

Theralase Hiring New Engineering Manager

Looks like they're finally replacing Wayne Embree of the laser division. ...

May 6, 2022

V.TLT

Theralase Hiring New IR Coordinator

Looks like Theralase is going to go back to responding to enquiries from...

May 6, 2022

V.TLT

RE:RE:Oncological Joint Ventures hit record heights in 2021

Hi ScienceFirst. Yes this article is in line with a lot of your recent posts....

May 5, 2022

V.TLT

Oncological Joint Ventures hit record heights in 2021

This article in Nature is apropos. There was a very interesting table I...

May 5, 2022

V.TLT

RE:Commercialization phase - Jan 2023 to December 2025

I think there will be a lot of long awaited progress in 2023. Along with...

May 4, 2022

V.TLT

RE:Commercialization phase - Jan 2023 to December 2025

That's how I see it too. I think Theralase is expecting to be granted...

May 4, 2022

V.TLT

Positive MD&A Tidbits

Theralase has not abandoned plans for an eventual GBM clinical trial: "...

May 2, 2022

V.TLT

RE:RE:The Good News

Eminently reasonable. I expect this case will be made vigorously to the FDA...

May 2, 2022

V.TLT

RE:RE:RE:RE:Observation/Question

5 to 8 months :) Lesalpes29 wrote: After mqny years of development, soon is...

May 1, 2022

V.TLT

RE:RE:RE:Potential 450 day CR of first 25 patients

Good post CancerSlayer. I think the worst case scenario still allows for...

April 30, 2022

V.TLT

Potential 450 day CR of first 25 patients

The 24% CR of the first 21 patients to reach 450 days = 5 out of 21 patients....

April 30, 2022

V.TLT

RE:RE:Theralase Releases Results

24% is 5% better than Keytruda achieved at 360 days and that was good enough...

April 30, 2022

V.TLT

Covid-19 Vaccine Animal Trial to start 2Q2022 & end 4Q2022

From the MD&A: "In February, 2022 Theralase® reported that...

April 29, 2022

V.TLT

RE:Theralase Releases Results

Theralase to submit 450 day report on first 25 patients in 4Q2022 in support...

April 29, 2022

V.TLT

RE:The Key to Theralase ACT

Sounds right to me Rumpl3StiltSkin. As you write, the dosimetry is the...

April 29, 2022